Spain: Synlab strengthens genetics offering with acquisition of Sistemas Genómicos in Spain

Synlab, Europe’s largest clinical laboratory and medical diagnostic services company, has kicked off its planned €200m (US$226.6m) 2022 M&A spend with the acquisition of Sistemas Genómicos of the Ascires Group in Spain, further strengthening its genetics offering. Sistemas Genómicos, a laboratory specialised in genetics and bioinformatics, will strategically complement Synlab’s capabilities in genetics and accelerate…

You must be a HMI Subscriber to view this content.

Subscribe Now »